These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 39165498)
1. Development and validation of an integrated system for lung cancer screening and post-screening pulmonary nodules management: a proof-of-concept study (ASCEND-LUNG). Jin Y; Mu W; Shi Y; Qi Q; Wang W; He Y; Sun X; Yang B; Cui P; Li C; Liu F; Liu Y; Wang G; Zhao J; Zhang Y; Zhang S; Cao C; Sun C; Hong N; Cai S; Tian J; Yang F; Chen K EClinicalMedicine; 2024 Sep; 75():102769. PubMed ID: 39165498 [TBL] [Abstract][Full Text] [Related]
2. Accurate classification of pulmonary nodules by a combined model of clinical, imaging, and cell-free DNA methylation biomarkers: a model development and external validation study. He J; Wang B; Tao J; Liu Q; Peng M; Xiong S; Li J; Cheng B; Li C; Jiang S; Qiu X; Yang Y; Ye Z; Zeng F; Zhang J; Liu D; Li W; Chen Z; Zeng Q; Fan JB; Liang W Lancet Digit Health; 2023 Oct; 5(10):e647-e656. PubMed ID: 37567793 [TBL] [Abstract][Full Text] [Related]
3. Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling. Guo W; Chen X; Liu R; Liang N; Ma Q; Bao H; Xu X; Wu X; Yang S; Shao Y; Tan F; Xue Q; Gao S; He J EBioMedicine; 2022 Jul; 81():104131. PubMed ID: 35780566 [TBL] [Abstract][Full Text] [Related]
4. Multi-omics integrated circulating cell-free DNA genomic signatures enhanced the diagnostic performance of early-stage lung cancer and postoperative minimal residual disease. Li Y; Jiang G; Wu W; Yang H; Jin Y; Wu M; Liu W; Yang A; Chervova O; Zhang S; Zheng L; Zhang X; Du F; Kanu N; Wu L; Yang F; Wang J; Chen K EBioMedicine; 2023 May; 91():104553. PubMed ID: 37027928 [TBL] [Abstract][Full Text] [Related]
5. Highly sensitive detection platform-based diagnosis of oesophageal squamous cell carcinoma in China: a multicentre, case-control, diagnostic study. Wang Y; Xing S; Xu YW; Xu QX; Ji MF; Peng YH; Wu YX; Wu M; Xue N; Zhang B; Xie SH; Zhu RD; Ou XY; Huang Q; Tian BY; Li HL; Jiang Y; Yao XB; Li JP; Ling L; Cao SM; Zhong Q; Liu WL; Zeng MS Lancet Digit Health; 2024 Oct; 6(10):e705-e717. PubMed ID: 39332854 [TBL] [Abstract][Full Text] [Related]
6. Accurate diagnosis of pulmonary nodules using a noninvasive DNA methylation test. Liang W; Chen Z; Li C; Liu J; Tao J; Liu X; Zhao D; Yin W; Chen H; Cheng C; Yu F; Zhang C; Liu L; Tian H; Cai K; Liu X; Wang Z; Xu N; Dong Q; Chen L; Yang Y; Zhi X; Li H; Tu X; Cai X; Jiang Z; Ji H; Mo L; Wang J; Fan JB; He J J Clin Invest; 2021 May; 131(10):. PubMed ID: 33793424 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Radiomic Models Based on Low-Dose and Standard-Dose CT for Prediction of Adenocarcinomas and Benign Lesions in Solid Pulmonary Nodules. Liu J; Xu H; Qing H; Li Y; Yang X; He C; Ren J; Zhou P Front Oncol; 2020; 10():634298. PubMed ID: 33604303 [TBL] [Abstract][Full Text] [Related]
8. Detecting pulmonary malignancy against benign nodules using noninvasive cell-free DNA fragmentomics assay. Xu S; Luo J; Tang W; Bao H; Wang J; Chang S; Zou Z; Fan X; Liu Y; Jiang C; Wu X ESMO Open; 2024 Aug; 9(8):103595. PubMed ID: 39088983 [TBL] [Abstract][Full Text] [Related]
9. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules. Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657 [TBL] [Abstract][Full Text] [Related]
10. Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma. Luo B; Ma F; Liu H; Hu J; Rao L; Liu C; Jiang Y; Kuangzeng S; Lin X; Wang C; Lei Y; Si Z; Chen G; Zhou N; Liang C; Jiang F; Liu F; Dai W; Liu W; Gao Y; Li Z; Li X; Zhou G; Li B; Zhang Z; Nian W; Luo L; Liu X BMC Med; 2022 Jan; 20(1):8. PubMed ID: 35027051 [TBL] [Abstract][Full Text] [Related]
11. Intelligent prognosis evaluation system for stage I-III resected non-small-cell lung cancer patients on CT images: a multi-center study. Zhang S; Liu X; Zhou L; Wang K; Shao J; Shi J; Wang X; Mu J; Gao T; Jiang Z; Chen K; Wang C; Wang G EClinicalMedicine; 2023 Nov; 65():102270. PubMed ID: 38106558 [TBL] [Abstract][Full Text] [Related]
12. A novel approach for the non-invasive diagnosis of pulmonary nodules using low-depth whole-genome sequencing of cell-free DNA. Zhang B; Liang H; Liu W; Zhou X; Qiao S; Li F; Tian P; Li C; Ma Y; Zhang H; Zhang Z; Nanjo S; Russo A; Puig-Butillé JA; Wu K; Wang C; Zhao X; Yue D Transl Lung Cancer Res; 2022 Oct; 11(10):2094-2110. PubMed ID: 36386459 [TBL] [Abstract][Full Text] [Related]
13. A clinically effective model based on cell-free DNA methylation and low-dose CT for risk stratification of pulmonary nodules. Liang W; Tao J; Cheng C; Sun H; Ye Z; Wu S; Guo Y; Zhang J; Chen Q; Liu D; Liu L; Tian H; Teng L; Zhong N; Fan JB; He J Cell Rep Med; 2024 Oct; 5(10):101750. PubMed ID: 39341207 [TBL] [Abstract][Full Text] [Related]
14. Development, Validation, and Comparison of Image-Based, Clinical Feature-Based and Fusion Artificial Intelligence Diagnostic Models in Differentiating Benign and Malignant Pulmonary Ground-Glass Nodules. Wang X; Gao M; Xie J; Deng Y; Tu W; Yang H; Liang S; Xu P; Zhang M; Lu Y; Fu C; Li Q; Fan L; Liu S Front Oncol; 2022; 12():892890. PubMed ID: 35747810 [TBL] [Abstract][Full Text] [Related]
15. External validation of radiomics-based predictive models in low-dose CT screening for early lung cancer diagnosis. Garau N; Paganelli C; Summers P; Choi W; Alam S; Lu W; Fanciullo C; Bellomi M; Baroni G; Rampinelli C Med Phys; 2020 Sep; 47(9):4125-4136. PubMed ID: 32488865 [TBL] [Abstract][Full Text] [Related]
16. Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study. Wu S; Hong G; Xu A; Zeng H; Chen X; Wang Y; Luo Y; Wu P; Liu C; Jiang N; Dang Q; Yang C; Liu B; Shen R; Chen Z; Liao C; Lin Z; Wang J; Lin T Lancet Oncol; 2023 Apr; 24(4):360-370. PubMed ID: 36893772 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography. González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules. Yang H; Chen H; Zhang G; Li H; Ni R; Yu Y; Zhang Y; Wu Y; Liu H BMC Cancer; 2022 Apr; 22(1):382. PubMed ID: 35397524 [TBL] [Abstract][Full Text] [Related]
19. A Noninvasive Multianalytical Approach for Lung Cancer Diagnosis of Patients with Pulmonary Nodules. Liu QX; Zhou D; Han TC; Lu X; Hou B; Li MY; Yang GX; Li QY; Pei ZH; Hong YY; Zhang YX; Chen WZ; Zheng H; He J; Dai JG Adv Sci (Weinh); 2021 Jul; 8(13):2100104. PubMed ID: 34258160 [TBL] [Abstract][Full Text] [Related]
20. Multidimensional Analysis of a Cell-Free DNA Whole Methylome Sequencing Assay for Early Detection of Gastric Cancer: Protocol for an Observational Case-Control Study. Han Y; Wei J; Wang W; Gao R; Shen N; Song X; Ni Y; Li Y; Xu LD; Chen W; Li X JMIR Res Protoc; 2023 Sep; 12():e48247. PubMed ID: 37728978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]